Prostate cancer pathway economics

Urology owns the prostate cancer chain — biopsy, MRI, treatment selection. Here’s how to capture the economics.

From the first elevated PSA to the final post-treatment follow-up, the patient journey is ours. We guide the workup, perform the biopsy, interpret the MRI in context, and counsel on a spectrum of treatments from active surveillance to robotic prostatectomy. This clinical ownership is a given. But for many urologists, especially those in private practice or on a partnership track, the economic ownership of this pathway remains fragmented and under-optimized.

Capturing the full value chain isn’t about just billing and coding more efficiently. It’s about structuring your practice, your investments, and your ancillary services to align with the clinical pathway you already command. It means thinking like an owner, not just a provider. This involves building equity in the facilities where you perform procedures, creating tax-efficient real estate structures, and leveraging sophisticated retirement plans that are only available to high-income business owners. This article breaks down the key financial and operational levers you can pull. For a broader look at practice models and resources, see the full urology hub.

ASC Ownership: Structuring for K-1 Income

The single biggest economic lever for a procedural specialty is moving cases out of the hospital and into an Ambulatory Surgery Center (ASC) that you own. For prostate biopsies, fiducial marker placements, and even certain therapies, the ASC model is a financial game-changer. When your group owns the ASC, you capture not only the professional fee for your work but also the facility fee that would otherwise go to the hospital.

Here’s how the structure works: The ASC is typically set up as a separate legal entity, often a Limited Liability Company (LLC), in which you and your partners are investors. Your medical practice pays you a W-2 salary for your clinical work. The ASC, as a separate business, generates its own profit from facility fees. This profit is then passed through to you and the other owners as a K-1 distribution.

This creates two distinct income streams, but the tax treatment is critical. The key distinction is whether your participation in the ASC is considered “active” or “passive” under IRS §469 passive activity rules. If you are a material participant in the ASC’s operations (which, as a surgeon bringing cases there, you almost certainly are), your K-1 income is active. More importantly, if the ASC were to generate a loss in a given year (e.g., during startup), those active losses can be used to offset your other active income, including your W-2 salary from the practice. Passive losses, in contrast, can generally only offset passive income.

The Planning Trap: Basis and At-Risk Limitations

Most physicians fall into a trap with the buy-in structure. Let’s say your buy-in is $200,000, but you finance $150,000 of it through a loan from the partnership. Your initial “basis” or “at-risk” amount is only the $50,000 cash you put in. If the ASC has a large paper loss in year one due to accelerated depreciation on equipment, and your share of that loss is $70,000, you can only deduct $50,000 of it. The remaining $20,000 is suspended until you increase your basis (by contributing more capital or paying down the loan). Understanding this from day one is crucial for tax planning.

Before you even get to tax structuring, the ASC has to be financially viable. This starts with understanding what commercial payers will actually reimburse for your key procedures. Modeling this accurately requires real-world data on negotiated rates, not just CMS fee schedules. This is where tools that provide CenterIQ rate intelligence become indispensable for building a pro forma that stands up to reality, ensuring your investment is sound from the start.

Medical Real Estate: The Lease-Back Strategy

Why pay rent to a landlord when you can pay it to yourself? The next layer of economic control is owning the very building where your practice operates. This is accomplished through a strategy known as a friendly lease-back.

The structure is straightforward:

1. You and your partners form a separate real estate holding company (again, typically an LLC).
2. This real estate LLC acquires the commercial medical office building.
3. The real estate LLC then leases the property to your medical practice at a fair market rate.

The financial mechanics are elegant. Your medical practice gets to deduct the full amount of its rent payments as a business expense, reducing its taxable income. Meanwhile, your real estate LLC receives that rent as income. After paying the mortgage, insurance, and taxes, the remaining cash flow is distributed to you as an owner, and you build equity in a valuable commercial asset.

The real power move here is depreciation. Commercial buildings can be depreciated over 39 years, but a technique called cost segregation can dramatically accelerate these deductions. A cost segregation study identifies components of the building that can be depreciated over much shorter periods (5, 7, or 15 years), such as specialty electrical, plumbing, cabinetry, and flooring. This front-loads your depreciation deductions, creating large paper losses in the early years of ownership that can offset your rental income.

The Spouse REPS Strategy: A Urologist’s Best Friend

By default, rental real estate is considered a passive activity, meaning those paper losses can only offset passive income. For most high-earning surgeons with little passive income, this is a problem. The solution is for one spouse to qualify for Real Estate Professional Status (REPS). Under IRS rules, this allows your real estate losses to become non-passive, meaning they can directly offset your high W-2 surgical income.

To qualify for REPS, a spouse must:

• Spend more than 750 hours during the year on real estate activities.
• Spend more than 50% of their total working time on those real estate activities.

The trap here is documentation. The IRS heavily scrutinizes REPS claims. You must maintain a contemporaneous time log detailing the hours spent on property management, tenant relations, and other qualifying activities. Without this proof, the deduction will be disallowed on audit.

Stacking Advanced Retirement Plans: The Cash Balance Strategy

Most physicians are familiar with a 401(k) and its profit-sharing component, which allows for pre-tax contributions of up to $73,500 (2026 projected limit). For a high-earning urology partner, this is a good start, but it’s just the beginning. The most powerful wealth-building tool available to you is a defined benefit plan, specifically a cash balance plan, stacked on top of your 401(k).

A cash balance plan is technically a pension plan, but it functions like a supercharged 401(k). Instead of being limited to a set contribution amount, the plan allows you to contribute (and deduct) the amount required to fund a future promised benefit. Because older, higher-income partners have fewer years until retirement to fund that benefit, their annual contribution limits can be enormous.

It is not uncommon for a urologist in their late 40s or 50s to contribute and deduct an additional $150,000, $200,000, or even over $300,000 per year into a cash balance plan. This is entirely separate from and in addition to their 401(k) contribution. For a surgeon in a high tax state, a $200,000 pre-tax contribution could translate into an immediate tax savings of $80,000 to $100,000 in a single year.

This strategy is particularly effective in small- to medium-sized private practices where the partners have similar ages and income levels. The plan design can be tailored to maximize contributions for the partner physicians while providing a more modest, affordable benefit for staff. It is the single most effective tool for reducing a high six-figure or seven-figure taxable income.

The 199A QBI Deduction: A Warning for Surgeons

When the Tax Cuts and Jobs Act of 2017 introduced the Section 199A Qualified Business Income (QBI) deduction, many practice owners celebrated the potential 20% deduction on pass-through income. However, for most successful urologists, this deduction is a mirage.

The reason is that the practice of medicine is classified as a “Specified Service Trade or Business” (SSTB). For owners of an SSTB, the QBI deduction is completely phased out once your taxable income exceeds a certain threshold. For 2026, this phase-out is projected to be complete at $485,900 for married couples filing jointly.

Nearly every partner-track urologist will have an income well above this level. This means you get zero benefit from the 199A deduction on your medical practice income. Many physicians hear about this “20% pass-through deduction” and mistakenly assume it applies to them, leading to surprise tax bills when their CPA delivers the bad news.

The key takeaway is not to despair, but to be strategic. Since you cannot use the 199A deduction, you must focus on the alternative strategies that *are* available to you. This is why the ASC, medical real estate, and cash balance plan strategies are so critical. They provide the massive, above-the-line deductions you need to meaningfully reduce your tax burden when QBI is off the table. Trying to stay under the income threshold is a fool’s errand; the goal is to earn as much as possible and then use more sophisticated tools to shelter it.

The Cash Balance Plan Overlay: Mechanics and Traps

Implementing a cash balance plan requires a deeper understanding of its mechanics. Unlike a 401(k), where you simply decide how much to contribute each year, a cash balance plan has mandatory funding requirements determined by an actuary. The plan document specifies a “hypothetical account balance” that grows with annual contribution credits (e.g., a percentage of pay) and an interest crediting rate (e.g., 5%). Your annual contribution is the amount the actuary calculates is needed to ensure the plan can meet those future obligations.

This creates a powerful deduction but also a significant responsibility. You cannot simply skip a contribution in a down year without consequence. This makes cash flow consistency important. The plan is best suited for mature, stable practices, not those with volatile revenue.

The Solo 1099 Urologist

This structure is also incredibly powerful for an independent urologist working as a 1099 contractor, perhaps doing locums or owning a solo S-corp. A solo practitioner can set up an Individual 401(k) and a one-person defined benefit/cash balance plan, allowing them to shelter a massive portion of their income without needing to cover any employees.

Common Traps to Avoid:

• Funding Inflexibility: Committing to a plan with contribution requirements that are too aggressive for your practice’s cash flow. It’s better to start with a more conservative plan design that you can comfortably fund every year.
• High Termination Costs: Winding down a defined benefit plan is a complex and expensive process involving actuaries and regulatory filings. You should view this as a long-term commitment, typically 5-10 years at a minimum.
• Investment Mismatch: The plan’s assets must achieve the target interest crediting rate specified in the plan document. If the investments underperform, you may be required to make up the shortfall with larger future contributions. The investment strategy must be conservative and aligned with the plan’s liabilities.

Owning the prostate cancer pathway means more than just clinical decision-making. It means building a financial and operational structure that captures the value you create. By integrating ancillary services like an ASC, strategically owning your real estate, and maximizing tax-deferred retirement savings, you can translate your clinical expertise into long-term wealth and professional autonomy.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 7, 2026